Fund Holdings — Finepoint Capital LP

Total Portfolio Value:
$822.35M
Total Bought:
$441.31M
Total Sold:
$261.7K
Net Transaction:
+$441.05M
Notable People:
Herbert Schwind Wagner, Fpcap Llc, Steven Laurence Lefkowitz
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
QXO, Inc.(QXO)025,750,781+25,750,781$0$406.09M49.38%+$406.09M
Liberty Broadband CorpCOM SER C1,994,5101,994,5100$109.34M$154.16M18.75%+$44.82M
Revolution Medicines, Inc.(RVMD)729,464731,960+2,496$28.31M$33.19M4.04%+$4.88M
argenx SEADR(ARGX)54,02854,428+400$23.23M$29.50M3.59%+$6.27M
Ascendis Pharma A/SADR(ASND)189,272190,072+800$25.81M$28.38M3.45%+$2.57M
Travere Therapeutics, Inc.(TVTX)1,776,7281,782,267+5,539$14.60M$24.93M3.03%+$10.33M
Springworks Therapeutics Inc638,352650,852+12,500$24.05M$20.85M2.54%-$3.19M
MoonLake ImmunotherapeuticsCL A(MLTX)388,835388,8350$17.10M$19.61M2.38%+$2.51M
Sarepta Therapeutics, Inc.(SRPT)132,835133,535+700$20.99M$16.68M2.03%-$4.31M
Lakefront Biotherapeutics NVADR(LKFT)542,762557,762+15,000$13.45M$16.06M1.95%+$2.61M
Arvinas, Inc.(ARVN)574,378574,3780$15.29M$14.15M1.72%-$1.14M
Acadia Pharmaceuticals Inc905,384905,3840$14.71M$13.92M1.69%-$787.7K
Cytokinetics, Incorporated(CYTK)256,449256,4490$13.89M$13.54M1.65%-$353.9K
Relay Therapeutics, Inc.(RLAY)1,605,3461,626,146+20,800$10.47M$11.51M1.40%+$1.05M
Prothena Corp PlcSHS
SHS
433,471433,4710$8.95M$7.25M0.88%-$1.69M
Solid Biosciences Inc961,251961,2510$5.45M$6.70M0.81%+$1.25M
EyePoint, Inc.(EYPT)707,404707,4040$6.15M$5.65M0.69%-$502.3K
Swiftmerge Acquisition CorpW EXP 12 13 202490,000490,0000$39.2K$39.2K0.00%$0
Compass Digital Acquisition CorpW EXP 09 29 202459,906459,9060$27.5K$28.1K0.00%+$506
Moneyhero LimitedW EXP 09 13 202
*W EXP 09/13/202
895,000895,0000$71.6K$26.9K0.00%-$44.8K
Marblegate Acquisition CorpW EXP 08 31 202735,000735,0000$26.8K$25.3K0.00%-$1.5K
Lakeshore Biopharma Co LtdW EXP 03 15 202489,999489,9990$33.4K$24.2K0.00%-$9.2K
Calidi Biotherapeutics Inc012,500+12,500$0$14.2K0.00%+$14.2K
Calidi Biotherapeutics IncW EXP 03 14 202655,200655,2000$27.6K$8.6K0.00%-$19.0K
Calidi Biotherapeutics Inc125,0000-125,000$25.0K$0—-$25.0K
Churchill Capital Corp ViiW EXP 02 29 202548,0000-548,000$191.8K$0—-$191.8K
Concord Acquisition Corp IIW EXP 99 99 999(CNDA)408,3330-408,333$44.9K$0—-$44.9K
Page 1 of 1
Finepoint Capital LP — 13F Holdings — Q3 2024 | TickerTrail